SK287525B6 - Farmaceutická formulácia s riadeným uvoľňovaním - Google Patents

Farmaceutická formulácia s riadeným uvoľňovaním Download PDF

Info

Publication number
SK287525B6
SK287525B6 SK1197-2001A SK11972001A SK287525B6 SK 287525 B6 SK287525 B6 SK 287525B6 SK 11972001 A SK11972001 A SK 11972001A SK 287525 B6 SK287525 B6 SK 287525B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical formulation
formulation according
clarithromycin
tablet
release
Prior art date
Application number
SK1197-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK11972001A3 (sk
Inventor
TEMELJOTOV Darja FER�EJ
Milojka Mohar
Mateja Salobir
Ljubomira Barbara Rebi�
Marko Opresnik
Original Assignee
Lek, Tovarna Farmacevtskih In Kemi�Nih Izdelkov, D. D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek, Tovarna Farmacevtskih In Kemi�Nih Izdelkov, D. D. filed Critical Lek, Tovarna Farmacevtskih In Kemi�Nih Izdelkov, D. D.
Publication of SK11972001A3 publication Critical patent/SK11972001A3/sk
Publication of SK287525B6 publication Critical patent/SK287525B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1197-2001A 1999-02-19 2000-02-17 Farmaceutická formulácia s riadeným uvoľňovaním SK287525B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI9900039A SI20150A (sl) 1999-02-19 1999-02-19 Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
PCT/SI2000/000002 WO2000048607A1 (en) 1999-02-19 2000-02-17 Directly compressible matrix for controlled release of single daily doses of clarithromycin

Publications (2)

Publication Number Publication Date
SK11972001A3 SK11972001A3 (sk) 2002-02-05
SK287525B6 true SK287525B6 (sk) 2011-01-04

Family

ID=20432410

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1197-2001A SK287525B6 (sk) 1999-02-19 2000-02-17 Farmaceutická formulácia s riadeným uvoľňovaním

Country Status (21)

Country Link
EP (1) EP1150686B1 (uk)
AT (1) ATE286736T1 (uk)
AU (1) AU776912B2 (uk)
BG (1) BG65324B1 (uk)
CY (1) CY1107454T1 (uk)
CZ (1) CZ302781B6 (uk)
DE (1) DE60017361T2 (uk)
DK (1) DK1150686T3 (uk)
EE (1) EE05422B1 (uk)
ES (1) ES2235834T3 (uk)
HR (1) HRP20010684B1 (uk)
HU (1) HUP0105481A3 (uk)
PL (1) PL196665B1 (uk)
PT (1) PT1150686E (uk)
RS (1) RS50298B (uk)
RU (1) RU2237480C2 (uk)
SI (2) SI20150A (uk)
SK (1) SK287525B6 (uk)
TR (1) TR200102396T2 (uk)
UA (1) UA74778C2 (uk)
WO (1) WO2000048607A1 (uk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200000054A2 (tr) * 2000-01-05 2001-08-21 Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇ Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
IN192748B (uk) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6673369B2 (en) 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
CA2405918A1 (en) * 2001-10-01 2003-04-01 Ind-Swift Limited Controlled release macrolide pharmaceutical formulations
SE0103369D0 (sv) * 2001-10-09 2001-10-09 Astrazeneca Ab Pharmaceutical formulation
US7037523B2 (en) 2001-11-02 2006-05-02 Wockhardt Limited Controlled release compositions for macrolide antimicrobial agents
AU2003214506A1 (en) * 2002-04-03 2003-10-13 Ranbaxy Laboratories Limited Clarithromycin formulations having improved bioavailability
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
WO2004010970A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005023221A1 (en) * 2003-09-05 2005-03-17 Ranbaxy Laboratories Limited Clarithromycin formulations having improved biovailability
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
BRPI0508743A (pt) * 2004-03-24 2008-01-22 Lupin Ltd composição farmacêutica com uma liberação estendida de eritromicina ou um derivado da mesma, método para o uso de uma composição farmacêutica e processo para a preparação de uma composição farmacêutica
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60163823A (ja) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd 経口投与製剤
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
JP2553882B2 (ja) * 1987-08-08 1996-11-13 富士写真光機株式会社 走査結像光学系
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
EP0744941B1 (en) * 1994-02-16 2003-06-04 Abbott Laboratories Process for preparing fine particle pharmaceutical formulations

Also Published As

Publication number Publication date
CZ302781B6 (cs) 2011-11-02
HRP20010684B1 (en) 2011-01-31
HRP20010684A2 (en) 2002-10-31
SK11972001A3 (sk) 2002-02-05
PL350419A1 (en) 2002-12-16
EP1150686A1 (en) 2001-11-07
AU776912B2 (en) 2004-09-23
HUP0105481A2 (hu) 2002-05-29
UA74778C2 (en) 2006-02-15
AU2704900A (en) 2000-09-04
HUP0105481A3 (en) 2003-04-28
EE05422B1 (et) 2011-06-15
DK1150686T3 (da) 2005-04-04
YU59201A (sh) 2004-07-15
EP1150686B1 (en) 2005-01-12
SI20150A (sl) 2000-08-31
ATE286736T1 (de) 2005-01-15
BG105914A (bg) 2002-05-31
BG65324B1 (bg) 2008-02-29
RS50298B (sr) 2009-09-08
WO2000048607A1 (en) 2000-08-24
CZ20012964A3 (cs) 2002-01-16
PT1150686E (pt) 2005-05-31
DE60017361D1 (de) 2005-02-17
PL196665B1 (pl) 2008-01-31
TR200102396T2 (tr) 2002-01-21
RU2237480C2 (ru) 2004-10-10
DE60017361T2 (de) 2005-12-22
EE200100433A (et) 2002-12-16
CY1107454T1 (el) 2012-12-19
ES2235834T3 (es) 2005-07-16
SI1150686T1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
SK287525B6 (sk) Farmaceutická formulácia s riadeným uvoľňovaním
JP3265680B2 (ja) 経口製剤用組成物
CA2654890C (en) Pharmaceutical composition
CN100560077C (zh) 药学组合物及其制备方法和用途
US7147869B2 (en) Rapidly disintegrating tablet comprising an acid-labile active ingredient
JP2001172201A (ja) 経口投与形のための味をマスキングするコーティングとしてのフィルム被覆の使用、経口投与形及びその製造法
JP4241041B2 (ja) 酸分解性活性成分を含有するペースト形の医薬品製造物
KR20080059409A (ko) 즉시방출형 및/또는 조절방출형 특성을 가진 약제학적 제형
JPH10502390A (ja) 医薬品用の徐放性マトリックス
US20100151018A1 (en) Sustained-release levetiracetam composition and preparation process
EP2529731A1 (en) Particulate preparation and method for producing the same
CA2423172A1 (en) Sustained release composition containing clarithromycin
EP1341523B1 (en) Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
US20120003307A1 (en) Levetiracetam controlled release composition
JPWO2003043661A1 (ja) 酸に不安定な生理活性化合物を含有する製剤組成物及びその製法
DE102005042875A1 (de) Schnell freisetzende Darreichungsformen für Antibiotika
US7713550B2 (en) Controlled release sodium valproate formulation
JP2002332226A (ja) 薬物顆粒の製造方法、および薬物顆粒、ならびにそれを用いた医薬製剤
IL192091A (en) Sustained release pharmaceutical compositions comprising liothyronine, process for their preparation and their use in the manufacture of medicaments
ZA200207737B (en) Granulated particles with masked taste.
WO2013181292A1 (en) Nitisinone formulations
JP3466921B2 (ja) 味マスキング医薬製剤
MXPA05004648A (es) Comprimidos orales de liberacion extendida y procedimientos de preparacion y uso de los mismos.
SK16642001A3 (sk) Farmaceutický prostriedok vo forme granulátu
AU2006335344A1 (en) Controlled release formulation of divalproic acid and its derivatives

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20130217